diclofenac and yf 476

diclofenac has been researched along with yf 476 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Boyce, M; Campbell, CA; Gillberg, L; Halim, MA; Hellström, PM; Näslund, E; Rudholm-Feldreich, T; Sanger, GJ; Theodorsson, E; Webb, DL	1

Other Studies

1 other study(ies) available for diclofenac and yf 476

Article	Year
The type 2 CCK/gastrin receptor antagonist YF476 acutely prevents NSAID-induced gastric ulceration while increasing iNOS expression. Naunyn-Schmiedeberg's archives of pharmacology, 2013, Volume: 386, Issue:1 Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Benzodiazepinones; Diclofenac; Esomeprazole; Gastric Mucosa; Gene Expression Regulation; Hydrogen-Ion Concentration; Male; Nitric Oxide Synthase Type II; Phenylurea Compounds; Rats; Rats, Sprague-Dawley; Receptor, Cholecystokinin B; Stomach Ulcer	2013

Article

Year

The type 2 CCK/gastrin receptor antagonist YF476 acutely prevents NSAID-induced gastric ulceration while increasing iNOS expression.

Naunyn-Schmiedeberg's archives of pharmacology, 2013, Volume: 386, Issue:1

Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Benzodiazepinones; Diclofenac; Esomeprazole; Gastric Mucosa; Gene Expression Regulation; Hydrogen-Ion Concentration; Male; Nitric Oxide Synthase Type II; Phenylurea Compounds; Rats; Rats, Sprague-Dawley; Receptor, Cholecystokinin B; Stomach Ulcer

2013